Search Within

Urvi A Shah

Formats
  1. Meeting Abstract (126)
  2. Journal Article (35)
  3. Research Letter (11)
  4. Review (9)
  5. Correspondence (3)
  6. Editorial (2)
Groups
  1. CTCR Scholars (186)
  2. Department of Medicine (186)
  3. Hematologic Malignancies, Division of (186)
  4. Center for Hematologic Malignancies (146)
  5. Myeloma (145)
  6. Hematologic Malignancies Research (140)

More Groups

People
  1. Alexander Lesokhin (136)
  2. Sham Mailankody (131)
  3. Malin Hultcrantz (125)
  4. Hani Hassoun (123)
  5. Neha Korde (123)
  6. Carlyn Rose Tan (112)

More People

Years
  1. 2025 (4)
  2. 2024 (38)
  3. 2023 (44)
  4. 2022 (44)
  5. 2021 (16)
  6. 2020 (20)

More Years

Publications
  1. Blood (66)
  2. Clinical Lymphoma, Myeloma and Leukemia (42)
  3. Journal of Clinical Oncology (15)
  4. Blood Cancer Journal (8)
  5. Blood Advances (6)
  6. Biology of Blood and Marrow Transplantation (4)

More Publications

Publishers
  1. American Society of Hematology (72)
  2. Elsevier Inc. (51)
  3. American Society of Clinical Oncology (15)
  4. Nature Publishing Group (13)
  5. American Association for Cancer Research (5)
  6. American Medical Association (4)

More Publishers

Results (186)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of active hepatitis C infection in relapse-free survival among patients with HIV-related diffuse large B-cell lymphoma
    Meeting Abstract

    Gonzalez-Lugo, J. D.; Acuna-Villaorduna, A.; Shah, U. A.; Friedman, E. W.
    Blood (2019)

    Fulltext@MSK | Save
  • FDA analysis: Impact of body mass index (BMI) on outcomes in relapsed-refractory multiple myeloma
    Meeting Abstract

    Ershler, R.; Kanapuru, B.; Gong, Y.; Shah, U. A.; Mailankody, S.; Landgren, O.; Theoret, M.; Gormley, N. J.; Farrell, A. T.; Pazdur, R.
    Blood (2019)

    Fulltext@MSK | Save
  • MALDI-TOF mass spectrometry in serum for the follow-up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy
    Meeting Abstract

    Eveillard, M.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Smith, E. L.; Hassoun, H.; Shah, U. A.; Lu, S. X.; Korde, N.; Landgren, O.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Barriers and outcomes of allogeneic stem cell transplant (alloSCT) for human T cell lymphotropic virus 1 (HTLV-1) associated adult T-cell lymphoma-leukemia (ATLL) in the United States (US) from a large cohort in a major tertiary center
    Meeting Abstract

    Adrianzen Herrera, D. A.; Vishnuvardhan, N.; Butler, M.; Shah, U. A.; Villaorduna, A. A.; Bachier Rodriguez, L.; Kornblum, N.; Derman, O.; Shastri, A.; Mantzaris, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma - Implications for staging
    Journal Article

    Acuna-Villaorduna, A.; Gonzalez-Lugo, J.; Ye, B. H.; Herrera, D. A. A.; Sica, R. A.; Shah, U.; Shah, N.; Kornblum, N.; Braunschweig, I.; Derman, O.; more...
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Depth of response and outcomes by initial therapy prior to autologous hematopoietic stem cell transplantation for multiple myeloma
    Meeting Abstract

    Shah, G.; Chung, D.; Scordo, M.; Seier, K.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; Mailankody, S.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Practice patterns with focal progression on daratumumab therapy
    Meeting Abstract

    Bal, S.; Peterson, T.; Landau, H.; Chung, D.; Giralt, S.; Korde, N.; Mailankody, S.; Smith, E.; Shah, U.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Unique racial patterns in rare T-cell lymphomas: A National Cancer Registry analysis from 2001 to 2015
    Meeting Abstract

    Shah, N.; Herrera, D. A.; Shah, U.; Kolla, B. C.; Kaur, G.; Sica, R. A.; Shastri, A.; Mantzaris, I.; Verma, A.; Janakiram, M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Exceptional response of refractory ATLL with MDM4 amplification to novel stapled peptide dual MDM4/2 inhibitor
    Meeting Abstract

    Janakiram, M.; Ye, H. B.; Carjaval, L.; Villaorduna, A.; Ramesh, K.; Shah, U.; Kornblum, N.; Fehn, K.; Braunschweig, I.; Ueda, K.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save